Ramdevbaba Solvent Ltd.
•₹ 92-3.06%
2026-08-21
PROS
- Company has a good return on equity (ROE) track record: 3 Years ROE 22.1%
- Company converts assets efficiently - asset turnover of 2.3x
CONS
- Company has a high debt-to-equity of 1.86x
- Operating cash flow has been negative in recent years
- A large part of profit comes from other income (35.7% of PBT)
- Poor cash conversion - profits are not backed by operating cash flow (CFO/PAT -0.29x)
- Free cash flow has been persistently negative
- Total debt has risen sharply - up 38.9% year on year
* The pros and cons are machine generated based on quantitative rules.
Peer comparison
EDIT COLUMNS| S.No. | Name | CMP Rs. | P/E | Mar Cap Rs.Cr. | Div Yld % | NP Qtr Rs.Cr. | Qtr Profit Var % | Sales Qtr Rs.Cr. | Qtr Sales Var % | ROCE % | OPM % |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 1. | GAEL | 173.35 | 19.11 | 7951.06 | 0.17 | 176.77 | 171.87 | 1594.22 | 23.47 | 12.43 | 14.55 |
| 2. | BNAGROCHEM | 239.00 | 136.87 | 2336.77 | 0.00 | 29.80 | 48.38 | 2576.08 | 1167.05 | 11.17 | 2.29 |
| 3. | RBS | 90.05 | 18.90 | 216.11 | 0.00 | — | — | — | — | 8.24 | — |
| 4. | SHANTI | 6.28 | 0.00 | 6.97 | 0.00 | 0.03 | -84.34 | 0.00 | -100.00 | -12.05 | — |
Detailed Comparison with:
Quarterly Results
Consolidated Figures in Rs. Crores / View Standalone
No quarterly results found
We don't have this information yet. Please check back later.
Profit & Loss
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|
| 698 | 686 | 929 | |
| 679 | 661 | 903 | |
| Operating Profit | 27 | 32 | 33 |
| OPM % | 4 | 5 | 4 |
| Other Income | 9 | 7 | 7 |
| Interest | 6 | 10 | 8 |
| Depreciation | 2 | 4 | 5 |
| 19 | 18 | 20 | |
| Tax % | 24 | 26 | 25 |
| Net Profit | 15 | 13 | 15 |
| EPS | 11 | 8 | 7 |
| Dividend Payout % | 0 | 0 | 0 |
| Minority Interest | 0 | 0 | 0 |
| Share of Associates | 0 | 0 | 0 |
| Adjusted EPS | 11 | 8 | 7 |
| Minority Interest | 0 | 0 | 0 |
| Share of Associates | 0 | 0 | 0 |
| Adjusted EPS | 11 | 8 | 7 |
Mar 2023
- 698
- 679
- Operating Profit
- 27
- OPM %
- 4
- Other Income
- 9
- Interest
- 6
- Depreciation
- 2
- 19
- Tax %
- 24
- Net Profit
- 15
- EPS
- 11
- Dividend Payout %
- 0
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- 11
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- 11
Mar 2024
- 686
- 661
- Operating Profit
- 32
- OPM %
- 5
- Other Income
- 7
- Interest
- 10
- Depreciation
- 4
- 18
- Tax %
- 26
- Net Profit
- 13
- EPS
- 8
- Dividend Payout %
- 0
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- 8
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- 8
Mar 2025
- 929
- 903
- Operating Profit
- 33
- OPM %
- 4
- Other Income
- 7
- Interest
- 8
- Depreciation
- 5
- 20
- Tax %
- 25
- Net Profit
- 15
- EPS
- 7
- Dividend Payout %
- 0
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- 7
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- 7
COMPOUNDED SALES GROWTH
- 10 Years:
- —
- 5 Years:
- —
- 3 Years:
- —
COMPOUNDED PROFIT GROWTH
- 10 Years:
- —
- 5 Years:
- —
- 3 Years:
- —
STOCK PRICE CAGR
- 10 Years:
- —
- 5 Years:
- —
- 3 Years:
- —
- 1 Year:
- -28%
RETURN ON EQUITY
- 10 Years:
- —
- 5 Years:
- —
- 3 Years:
- 22%
- Last Year:
- 14%
Balance Sheet
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|
| LIABILITIES | - | - | - |
| Equity Capital | 5 | 16 | 23 |
| 43 | 57 | 121 | |
| 45 | 58 | 55 | |
| Trade Payables | 30 | 32 | 31 |
| 67 | 166 | 253 | |
| Total Liabilities | 191 | 329 | 482 |
| ASSETS | - | - | - |
| 62 | 99 | 103 | |
| Capital Work in Progress | 28 | 69 | 189 |
| 47 | 61 | 78 | |
| 0 | 41 | 32 | |
| Cash & Bank | 0 | 8 | 4 |
| 54 | 51 | 76 | |
| Total Assets | 191 | 329 | 482 |
| Total Debt | 99 | 192 | 267 |
| Net Working Capital | 1 | 32 | 63 |
| Contingent Liabilities | 2 | 9 | 3 |
| Book Value per Share | 1042.72 | 44.88 | 62.81 |
| Face Value | 100.00 | 10.00 | 10.00 |
| Total Debt | 99 | 192 | 267 |
| Net Working Capital | 1 | 32 | 63 |
| Contingent Liabilities | 2 | 9 | 3 |
| Book Value per Share | 1042.72 | 44.88 | 62.81 |
| Face Value | 100.00 | 10.00 | 10.00 |
Mar 2023
- Equity Capital
- 5
- 43
- 45
- Trade Payables
- 30
- 67
- Total Liabilities
- 191
- 62
- Capital Work in Progress
- 28
- 47
- 0
- Cash & Bank
- 0
- 54
- Total Assets
- 191
- Total Debt
- 99
- Net Working Capital
- 1
- Contingent Liabilities
- 2
- Book Value per Share
- 1042.72
- Face Value
- 100.00
- Total Debt
- 99
- Net Working Capital
- 1
- Contingent Liabilities
- 2
- Book Value per Share
- 1042.72
- Face Value
- 100.00
Mar 2024
- Equity Capital
- 16
- 57
- 58
- Trade Payables
- 32
- 166
- Total Liabilities
- 329
- 99
- Capital Work in Progress
- 69
- 61
- 41
- Cash & Bank
- 8
- 51
- Total Assets
- 329
- Total Debt
- 192
- Net Working Capital
- 32
- Contingent Liabilities
- 9
- Book Value per Share
- 44.88
- Face Value
- 10.00
- Total Debt
- 192
- Net Working Capital
- 32
- Contingent Liabilities
- 9
- Book Value per Share
- 44.88
- Face Value
- 10.00
Mar 2025
- Equity Capital
- 23
- 121
- 55
- Trade Payables
- 31
- 253
- Total Liabilities
- 482
- 103
- Capital Work in Progress
- 189
- 78
- 32
- Cash & Bank
- 4
- 76
- Total Assets
- 482
- Total Debt
- 267
- Net Working Capital
- 63
- Contingent Liabilities
- 3
- Book Value per Share
- 62.81
- Face Value
- 10.00
- Total Debt
- 267
- Net Working Capital
- 63
- Contingent Liabilities
- 3
- Book Value per Share
- 62.81
- Face Value
- 10.00
Cash Flows
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|
| 11 | -23 | -1 | |
| Cash from Investing | -39 | -83 | -128 |
| Cash from Financing | 28 | 113 | 125 |
| 0 | 7 | -3 | |
| Free Cash Flow | 11 | -105 | -129 |
| OCF / Net Profit | 0.74 | -1.74 | -0.05 |
| Cumulative 5-Year FCF | 0 | 0 | 0 |
| OCF / Net Profit | 0.74 | -1.74 | -0.05 |
| Cumulative 5-Year FCF | 0 | 0 | 0 |
Mar 2023
- 11
- Cash from Investing
- -39
- Cash from Financing
- 28
- 0
- Free Cash Flow
- 11
- OCF / Net Profit
- 0.74
- Cumulative 5-Year FCF
- 0
- OCF / Net Profit
- 0.74
- Cumulative 5-Year FCF
- 0
Mar 2024
- -23
- Cash from Investing
- -83
- Cash from Financing
- 113
- 7
- Free Cash Flow
- -105
- OCF / Net Profit
- -1.74
- Cumulative 5-Year FCF
- 0
- OCF / Net Profit
- -1.74
- Cumulative 5-Year FCF
- 0
Mar 2025
- -1
- Cash from Investing
- -128
- Cash from Financing
- 125
- -3
- Free Cash Flow
- -129
- OCF / Net Profit
- -0.05
- Cumulative 5-Year FCF
- 0
- OCF / Net Profit
- -0.05
- Cumulative 5-Year FCF
- 0
Ratios
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|
| PER SHARE | - | - | - |
| EPS (₹) | 320.21 | 8.04 | 6.56 |
| Book Value (₹) | 1042.72 | 44.88 | 62.81 |
| Dividend per Share (₹) | 0.00 | 0.00 | 0.00 |
| Cash EPS (₹) | 12.30 | 10.67 | 8.66 |
| PROFITABILITY | - | - | - |
| Operating Margin % | 3.90% | 3.66% | 2.78% |
| Net Margin % | 2.11% | 1.90% | 1.61% |
| ROE % | 30.71% | 21.61% | 13.84% |
| ROCE % | 16.97% | 13.32% | 8.24% |
| 7.71% | 5.02% | 3.69% | |
| EFFICIENCY | - | - | - |
| Debtor Days | 20 | 21 | 14 |
| Inventory Days | 25 | 29 | 27 |
| Payable Days | 19 | 20 | 14 |
| 26 | 30 | 27 | |
| FINANCIAL HEALTH | - | - | - |
| Debt to Equity (x) | 2.07x | 2.64x | 1.86x |
| Interest Coverage (x) | 4.40x | 2.82x | 3.49x |
| 1.01x | 1.27x | 1.55x | |
| GROWTH | - | - | - |
| Revenue Growth % | 0.00% | -1.62% | 35.29% |
| Operating Profit Growth % | 0.00% | 16.58% | 4.03% |
| Net Profit Growth % | 0.00% | -11.27% | 14.90% |
| 0.00% | -97.49% | -18.37% | |
| VALUATION | - | - | - |
| P/E (x) | 0.00x | 0.00x | 17.47x |
| P/B (x) | 0.00x | 0.00x | 1.83x |
| Dividend Yield % | 0.00% | 0.00% | 0.00% |
| 0.00x | 6.33x | 15.90x |
Mar 2023
- EPS (₹)
- 320.21
- Book Value (₹)
- 1042.72
- Dividend per Share (₹)
- 0.00
- Cash EPS (₹)
- 12.30
- Operating Margin %
- 3.90%
- Net Margin %
- 2.11%
- ROE %
- 30.71%
- ROCE %
- 16.97%
- 7.71%
- Debtor Days
- 20
- Inventory Days
- 25
- Payable Days
- 19
- 26
- Debt to Equity (x)
- 2.07x
- Interest Coverage (x)
- 4.40x
- 1.01x
- Revenue Growth %
- 0.00%
- Operating Profit Growth %
- 0.00%
- Net Profit Growth %
- 0.00%
- 0.00%
- P/E (x)
- 0.00x
- P/B (x)
- 0.00x
- Dividend Yield %
- 0.00%
- 0.00x
Mar 2024
- EPS (₹)
- 8.04
- Book Value (₹)
- 44.88
- Dividend per Share (₹)
- 0.00
- Cash EPS (₹)
- 10.67
- Operating Margin %
- 3.66%
- Net Margin %
- 1.90%
- ROE %
- 21.61%
- ROCE %
- 13.32%
- 5.02%
- Debtor Days
- 21
- Inventory Days
- 29
- Payable Days
- 20
- 30
- Debt to Equity (x)
- 2.64x
- Interest Coverage (x)
- 2.82x
- 1.27x
- Revenue Growth %
- -1.62%
- Operating Profit Growth %
- 16.58%
- Net Profit Growth %
- -11.27%
- -97.49%
- P/E (x)
- 0.00x
- P/B (x)
- 0.00x
- Dividend Yield %
- 0.00%
- 6.33x
Mar 2025
- EPS (₹)
- 6.56
- Book Value (₹)
- 62.81
- Dividend per Share (₹)
- 0.00
- Cash EPS (₹)
- 8.66
- Operating Margin %
- 2.78%
- Net Margin %
- 1.61%
- ROE %
- 13.84%
- ROCE %
- 8.24%
- 3.69%
- Debtor Days
- 14
- Inventory Days
- 27
- Payable Days
- 14
- 27
- Debt to Equity (x)
- 1.86x
- Interest Coverage (x)
- 3.49x
- 1.55x
- Revenue Growth %
- 35.29%
- Operating Profit Growth %
- 4.03%
- Net Profit Growth %
- 14.90%
- -18.37%
- P/E (x)
- 17.47x
- P/B (x)
- 1.83x
- Dividend Yield %
- 0.00%
- 15.90x
Documents
Announcements
Nothing filed yet.
Annual Reports
Credit Ratings
Nothing filed yet.
Concalls
Nothing filed yet.